Most cited papers from Orbus Therapeutics (United States)
What are the most cited papers from Orbus Therapeutics (United States)?
The most cited paper from Orbus Therapeutics (United States) is "Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Guideline Rapid Recommendation Update" (Jaishri O'Neill Blakeley et al., 2025), with 15 citations. Next come "Phase 1b/2 study of orally administered pexidartinib in combination with radiation therapy and temozolomide in patients with newly diagnosed glioblastoma" (10) and "Integrating Human Intestinal Organoids into FDA's New Approach Methodologies for Drug Discovery" (4).
Showing 9 of 9 papers. Every paper is listed.
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.